What is Accelerate Diagnostics Inc (AXDX) stock price today?

Accelerate Diagnostics Inc (AXDX) currently trades at $0.03 per share. The stock has a market capitalization of $859920.00 and a P/E ratio of —x.

Is AXDX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Accelerate Diagnostics Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Accelerate Diagnostics Inc's revenue and earnings?

Accelerate Diagnostics Inc has trailing twelve-month (TTM) revenue of $11.70M with profit margins of 0.00%. Earnings per share (EPS) is $-2.15.

AXDX

Accelerate Diagnostics Inc

NASDAQ: AXDX · HEALTHCARE · MEDICAL DEVICES

$0.03

+0.00% today

Updated 2026-04-29

Market cap

$859920.00

P/E ratio

—

P/S ratio

0.07x

EPS (TTM)

$-2.15

Dividend yield

—

52W range

$0 – $1

Volume

—

Market cap

$859920.00

P/E ratio

—

P/S ratio

0.07x

EPS (TTM)

$-2.15

Dividend yield

—

52W range

$0 – $1

Volume

—

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$1.50

+4311.76%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-5.07M

- Revenue declining -7.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$11.78M	$12.75M	$12.06M	$11.70M	$11.70M
Net income	$-77.70M	$-62.49M	$-61.62M	$-50.05M	$-9.59M
EPS	—	—	—	—	$-2.15
Free cash flow	$-47.93M	$-49.28M	$-41.23M	$-24.70M	$-5.07M
Profit margin	-659.50%	-490.06%	-510.97%	-427.81%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AXDX	$859920.00	25	2.7	3.0	5.0	5.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Accelerate Diagnostics Inc trades at $0.03. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $11.70M.

Frequently asked questions

What is Accelerate Diagnostics Inc's stock price?

Accelerate Diagnostics Inc (AXDX) trades at $0.03.

Is Accelerate Diagnostics Inc overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Accelerate Diagnostics Inc (AXDX)?

The analyst target price is $1.50, representing +4311.8% upside from the current price of $0.03.

What is Accelerate Diagnostics Inc's revenue?

TTM revenue is $11.70M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.07x

ROE—

Beta0.22

50D MA$0.53

200D MA$1.25

Shares out0.03B

Float0.01B

Short ratio—

Avg volume—

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AXDX vs LLY →AXDX vs JNJ →AXDX vs ABBV →Stock screener →